Press release
Strong Growth Ahead: Alzheimer's Disease Diagnostic Market Size To Grow At Arecord 10.7% Cagr By 2029
Alzheimer's Disease Diagnostic
How Big Is the Alzheimer's Disease Diagnostic Market Size Expected to Be by 2034?
The market size for diagnosing Alzheimer's disease has seen rapid expansion in recent years. The expected growth is from $6.56 billion in 2024 to $7.28 billion in 2025, with a compound annual growth rate (CAGR) of 11%. This significant increase over the historical period can be tied to factors such as increased incidence of Alzheimer's disease and dementia, escalating awareness regarding the need for early prognosis for effective management, technological advancements in imaging methodologies like MRI and PET scans, heightened investment in research and development dealing with neurodegenerative diseases, as well as government interventions and financial support for Alzheimer's research and diagnosis.
The market size for diagnosing Alzheimer's disease is projected to experience a substantial increase over the upcoming years. It is anticipated to reach $10.91 billion by 2029, showing a compound annual growth rate (CAGR) of 10.7%. The expected expansion during the forecast period can be linked to factors such as the advancement in blood-based biomarkers for non-intrusive diagnosis, the surge for personalized and precision diagnostics, the incorporation of artificial intelligence and machine learning in early detection tools, the increasing use of digital health technologies for remote monitoring and diagnosis, and the enlargement of health infrastructure in emerging markets to enhance accessibility. The forecasted period will also witness significant trends like the rise of diagnostic approaches that blend imaging, biomarkers, and cognitive tests, a heightened emphasis on point-of-care diagnostic solutions for quicker results, the creation of wearable devices for constant cognitive health monitoring, growing synergy between biotech firms and research institutions for novel solutions, and the expansion in direct-to-consumer genetic testing for assessing Alzheimer's risk.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21093
What Are the Emerging Segments Within the Alzheimer's Disease Diagnostic Market?
The alzheimer's disease diagnostic market covered in this report is segmented -
1) By Type: Triage, Diagnosis, Screening
2) By Diagnostic Technique: Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests
3) By End User: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center
Subsegments:
1) By Triage: Cognitive Testing, Imaging Techniques
2) By Diagnosis: Biomarker Testing, Neuroimaging
3) By Screening: Neuropsychological Testing, Genetic Testing
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21093&type=smp
What Long-Term Drivers Are Shaping Alzheimer's Disease Diagnostic Market Trends?
The surge in chronic illnesses is anticipated to fuel the expansion of the alzheimer's disease diagnostic market. Chronic illness, a health problem lasting more than three months, is escalating due to several closely interlinked factors, such as lifestyle choices, environmental factors, genes, and social-economic conditions. Chronic conditions like heart problems, diabetes, and high blood pressure enhance the likelihood of developing Alzheimer's disease (AD) and other kinds of dementia. As per the American Heart Association Inc.'s report in January 2022, there may be up to 9.3 million cases of brain disorders in the US by 2060. The existing number is increasing rapidly in the US, and one out of six people across the globe already has a brain disorder. The global count of brain disorders is expected to hit 1 billion by 2021. Thus, the rise in chronic illnesses is expected to boost the alzheimer's disease diagnostic market.
Who Are the Top Competitors in Key Alzheimer's Disease Diagnostic Market Segments?
Major companies operating in the alzheimer's disease diagnostic market are Pfizer Inc., AbbVie, Bristol Myers Squibb Company, Hoffmann-La Roche, Eli Lilly and Company, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Daiichi Sankyo Co., Sysmex, Lantheus, Quanterix, FujireBio, TauRx Pharmaceuticals Ltd, AC Immune, C2N diagnostics, AXON Neuroscience, Neuro-Bio Ltd, Anavex Life Sciences Corp., Treventis Corporation
What Alzheimer's Disease Diagnostic Market Trends Are Gaining Traction Across Different Segments?
Leading firms in the Alzheimer's disease diagnostic market are concentrating on improving blood-based biomarker tests, an advancement expected to streamline the diagnostic process for Alzheimer's disease. It could lessen the need for invasive procedures and increase access to prompt treatment for patients. In October 2023, Quanterix, an American biotech research firm, introduced the LucentAD p-Tau 217 test, a blood biomarker that can accurately detect Alzheimer's pathology. Traditional methods of detecting cerebrospinal fluid (CSF) biomarkers, such as positron emission tomography (PET) or lumbar puncture, are expensive, invasive, and not universally accessible. Additionally, Quanterix has combined its highly sensitive SimoaÒ technology with the proven p-Tau 217 antibodies from J&J Innovative Medicine, resulting in exceptional accuracy and a simplified procedure.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/alzheimers-disease-diagnostic-global-market-report
Which Regions Are Becoming Hubs for Alzheimer's Disease Diagnostic Market Innovation?
North America was the largest region in the alzheimer's disease diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alzheimer's disease diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Alzheimer's Disease Diagnostic Market?
2. What is the CAGR expected in the Alzheimer's Disease Diagnostic Market?
3. What Are the Key Innovations Transforming the Alzheimer's Disease Diagnostic Industry?
4. Which Region Is Leading the Alzheimer's Disease Diagnostic Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strong Growth Ahead: Alzheimer's Disease Diagnostic Market Size To Grow At Arecord 10.7% Cagr By 2029 here
News-ID: 4069571 • Views: …
More Releases from The Business Research Company
Increasing Demand For Personal Care And Cosmetic Products Drives Coconut Oil Mar …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Coconut Oil Market Size By 2025?
In the last few years, the coconut oil market has experienced substantial growth. The market size is projected to rise from $5.03 billion in 2024 to $5.49 billion in 2025, which is an annual compound growth rate (CAGR) of 9.2%. This growth in the…
Driving Cloud Security Market Growth in 2025: The Role of Countering The Surge I …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cloud Security Market Size Growth Forecast: What to Expect by 2025?
The size of the cloud security market has notably increased over the past few years. The market is projected to expand from a value of $17.11 billion in 2024 to reach $19.71 billion in 2025, representing a compound annual growth rate (CAGR) of…
Comprehensive Cloud Based Contact Center Market Forecast 2025-2034: Growth Trend …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cloud Based Contact Center Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The expansion in the cloud based contact center market has been substantial in the past few years. Its market size is projected to rise from $26.36 billion in 2024 to $31.04 billion in 2025, escalating at a compound…
Explosive Growth In The Consumer Electronics Fuels Circuit Protection Market: Po …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Circuit Protection Market Through 2025?
In recent times, the circuit protection market has experienced significant expansion. The market, which was valued at $54.5 billion in 2024, is projected to rise to $59.88 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. Factors contributing to…
More Releases for Alzheimer
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
Anti-β-Alzheimer Therapies Market : Consumption, Revenue, Applications With Maj …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer…
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer…
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Alzheimer Diagnostic Tests Market
GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
